• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呼吸重症监护病房的药物治疗随访:结果描述与分析

Pharmacotherapeutic follow-up in a respiratory intensive care unit: description and analysis of results.

作者信息

Silva Ana Carolina de Souza E, Sousa Domingos Sávio de Carvalho, Perraud Eunice Bobô de Carvalho, Oliveira Fátima Rosane de Almeida, Martins Bruna Cristina Cardoso

机构信息

Hospital de Messejana Dr. Carlos Alberto Studart Gomes, Fortaleza, CE, Brazil.

Universidade Federal do Ceará, Fortaleza, CE, Brazil.

出版信息

Einstein (Sao Paulo). 2018 Jun 21;16(2):eAO4112. doi: 10.1590/S1679-45082018AO4112.

DOI:10.1590/S1679-45082018AO4112
PMID:29947642
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6019241/
Abstract

OBJECTIVE

To describe and evaluate the pharmacotherapeutic follow-up by a clinical pharmacist in an intensive care unit.

METHODS

A descriptive and cross-sectional study carried out from August to October 2016. The data were collected through a form, and pharmacotherapeutic follow-up conducted by a clinical pharmacist at the respiratory intensive care unit of a tertiary hospital. The problems recorded in the prescriptions were quantified, classified and evaluated according to severity; the recommendations made by the pharmacist were analyzed considering the impact on pharmacotherapy. The medications involved in the problems were classified according to the Anatomical Therapeutic Chemical Classification System.

RESULTS

Forty-six patients were followed up and 192 pharmacotherapy-related problems were registered. The most prevalent problems were missing information on the prescription (33.16%), and those with minor severity (37.5%). Of the recommendations made to optimize pharmacotherapy, 92.7% were accepted, particularly those on inclusion of infusion time (16.67%), and dose appropriateness (13.02%), with greater impact on toxicity (53.6%). Antimicrobials, in general, for systemic use were drug class most often related to problems in pharmacotherapy (53%).

CONCLUSION

Pharmacotherapeutic follow-up conducted by a pharmacist in a respiratory intensive care unit was able to detect problems in drug therapy and to make clinically relevant recommendations.

摘要

目的

描述并评估临床药师在重症监护病房开展的药物治疗随访工作。

方法

于2016年8月至10月进行一项描述性横断面研究。通过一份表格收集数据,由一名临床药师在一家三级医院的呼吸重症监护病房开展药物治疗随访。对处方中记录的问题按照严重程度进行量化、分类和评估;分析药师提出的建议对药物治疗的影响。根据解剖学治疗学化学分类系统对涉及问题的药物进行分类。

结果

对46例患者进行了随访,共记录了192个与药物治疗相关的问题。最常见的问题是处方信息缺失(33.16%),以及严重程度较轻的问题(37.5%)。在为优化药物治疗而提出的建议中,92.7%被采纳,尤其是关于加入输注时间的建议(16.67%)和剂量适宜性的建议(13.02%),对毒性的影响更大(53.6%)。一般而言,全身用抗菌药物是最常与药物治疗问题相关的药物类别(53%)。

结论

临床药师在呼吸重症监护病房开展的药物治疗随访能够发现药物治疗中的问题并提出具有临床相关性的建议。

相似文献

1
Pharmacotherapeutic follow-up in a respiratory intensive care unit: description and analysis of results.呼吸重症监护病房的药物治疗随访:结果描述与分析
Einstein (Sao Paulo). 2018 Jun 21;16(2):eAO4112. doi: 10.1590/S1679-45082018AO4112.
2
Pharmacist recommendations in an intensive care unit: three-year clinical activities.重症监护病房的药师建议:三年临床活动
Rev Bras Ter Intensiva. 2015 Apr-Jun;27(2):149-54. doi: 10.5935/0103-507X.20150026.
3
Impact of medication therapy management on pharmacotherapy safety in an intensive care unit.药物治疗管理对重症监护病房药物治疗安全性的影响。
Int J Clin Pharm. 2019 Feb;41(1):179-188. doi: 10.1007/s11096-018-0763-0. Epub 2018 Dec 15.
4
Short Stay Unit and Emergency Department: Pharmacotherapeutic Interventions and Its Impact.短期住院部与急诊科:药物治疗干预及其影响
Am J Ther. 2016 Nov/Dec;23(6):e1307-e1314. doi: 10.1097/MJT.0000000000000204.
5
Impact of pharmacist interventions in older patients: a prospective study in a tertiary hospital in Germany.药剂师干预对老年患者的影响:德国一家三级医院的前瞻性研究。
Clin Interv Aging. 2016 Sep 26;11:1343-1350. doi: 10.2147/CIA.S109048. eCollection 2016.
6
Identification and resolution of drug-related problems in a tertiary hospital respiratory unit in China.中国某三甲医院呼吸科的药物相关问题的识别与解决。
Int J Clin Pharm. 2019 Dec;41(6):1570-1577. doi: 10.1007/s11096-019-00922-3. Epub 2019 Oct 25.
7
[Pharmacists' interventions conducted by hospital pharmacists on psychotropic drugs pharmacotherapy].[医院药剂师对精神药物药物治疗的干预措施]
Encephale. 2015 Sep;41(4):339-45. doi: 10.1016/j.encep.2014.10.001. Epub 2014 Dec 16.
8
Evaluation of a method for drug-related problems identification and classification in hospital setting: applicability and reliability.医院环境中药物相关问题识别与分类方法的评估:适用性与可靠性
Int J Clin Pharm. 2020 Feb;42(1):193-200. doi: 10.1007/s11096-019-00957-6. Epub 2019 Dec 21.
9
Impact of the clinical pharmacist interventions on prevention of pharmacotherapy related problems in the paediatric intensive care unit.临床药师干预对儿科重症监护病房药物治疗相关问题预防的影响。
Int J Clin Pharm. 2018 Jun;40(3):513-519. doi: 10.1007/s11096-018-0632-x. Epub 2018 Mar 30.
10
Evaluation of an automated surveillance system using trigger alerts to prevent adverse drug events in the intensive care unit and general ward.评估一种使用触发警报来预防重症监护病房和普通病房中药物不良事件的自动监测系统。
Drug Saf. 2015 Mar;38(3):311-7. doi: 10.1007/s40264-015-0272-1.

本文引用的文献

1
Pharmacist recommendations in an intensive care unit: three-year clinical activities.重症监护病房的药师建议:三年临床活动
Rev Bras Ter Intensiva. 2015 Apr-Jun;27(2):149-54. doi: 10.5935/0103-507X.20150026.
2
Analysis of clinical pharmacist interventions in a tertiary teaching hospital in Brazil.巴西一家三级教学医院临床药师干预措施分析
Einstein (Sao Paulo). 2013 Apr-Jun;11(2):190-6. doi: 10.1590/s1679-45082013000200010.
3
Prescribing errors intercepted by clinical pharmacists in paediatrics and obstetrics in a tertiary hospital in Spain.西班牙一家三级医院儿科和妇产科临床药师发现的处方错误。
Eur J Clin Pharmacol. 2012 Sep;68(9):1339-45. doi: 10.1007/s00228-012-1257-y. Epub 2012 Mar 6.
4
Medication prescribing errors in the intensive care unit of Jimma University Specialized Hospital, Southwest Ethiopia.在埃塞俄比亚西南部的吉姆马大学专科医院的重症监护病房发生的药物处方错误。
J Multidiscip Healthc. 2011;4:377-82. doi: 10.2147/JMDH.S24671. Epub 2011 Oct 31.
5
On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study.医院药剂师参与荷兰重症监护病房可减少处方错误和相关的患者伤害:一项干预研究。
Crit Care. 2010;14(5):R174. doi: 10.1186/cc9278. Epub 2010 Oct 4.
6
Incidence of adverse drug events and medication errors in Japan: the JADE study.日本药物不良事件和用药错误的发生率:JADE 研究。
J Gen Intern Med. 2011 Feb;26(2):148-53. doi: 10.1007/s11606-010-1518-3. Epub 2010 Sep 25.
7
Medication errors in critical care: risk factors, prevention and disclosure.重症监护中的用药错误:风险因素、预防与披露
CMAJ. 2009 Apr 28;180(9):936-43. doi: 10.1503/cmaj.080869.
8
Medication errors in an intensive care unit.重症监护病房中的用药错误。
J Adv Nurs. 2009 Jun;65(6):1259-67. doi: 10.1111/j.1365-2648.2009.04979.x. Epub 2009 Apr 3.
9
The critical care clinical pharmacist: evolution of an essential team member.重症监护临床药剂师:重要团队成员的演变
Crit Care Med. 2006 Mar;34(3 Suppl):S46-51. doi: 10.1097/01.CCM.0000199990.68341.33.
10
[Adverse events -- or is it normal?].
Rev Assoc Med Bras (1992). 2004 Apr-Jun;50(2):114. doi: 10.1590/s0104-42302004000200008. Epub 2004 Jul 21.